PRAX
Praxis Precision Medicines, Inc.
Stock
$295.51+8.60 (+3.00%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$305M | −$249M | −$132M | −$111M | −$185M | −$125M | −$53M | −$33M |
| Capital expenditures | $307K | $56K | $0 | $50K | $444K | $1.1M | $0 | $103K |
| Free cash flow | −$305M | −$249M | −$132M | −$111M | −$185M | −$126M | −$53M | −$34M |
| Stock-based compensation | $46M | $34M | $41M | $25M | $29M | $23M | $5.2M | $668K |
| Free cash flow margin | — | — | −1,540.5% | −4,543.8% | — | — | — | — |